Cited by CrossRef (9)
- Han Na Jung, Chang Hee Jung. Pharmacologic treatment of obesity. J Korean Med Assoc 2022;65:408

- Han Na Jung, Chang Hee Jung. The Upcoming Weekly Tides (Semaglutide vs. Tirzepatide) against Obesity: STEP or SURPASS?. Journal of Obesity & Metabolic Syndrome 2022;31:28

- Vishnupriya Veeraraghavan. Obesogenic Behavior and Binge Eating Disorder in an Elderly Female with Schizophrenia. Journal of Obesity & Metabolic Syndrome 2021;30:184

- Bo-Yeon Kim, Seon Mee Kang, Jee-Hyun Kang, Seo Young Kang, Kyoung Kon Kim, Kyoung-Bae Kim, Bomtaeck Kim, Seung Jun Kim, Yang-Hyun Kim, Jung-Hwan Kim, Jae Hyun Kim, Eun Mi Kim, Ga Eun Nam, Ji Yeon Park, Jang Won Son, Yun-A Shin, Hye-Jung Shin, Tae Jung Oh, Hyug Lee, Eon-Ju Jeon, Sochung Chung, Yong Hee Hong, Chong Hwa Kim. 2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea. Journal of Obesity & Metabolic Syndrome 2021;30:81

- Win Min Oo, Ali Mobasheri, David J Hunter. A narrative review of anti-obesity medications for obese patients with osteoarthritis. Expert Opinion on Pharmacotherapy 2022;23:1381

- Jung-Mi Oh, Sungkun Chun. Ginsenoside CK Inhibits the Early Stage of Adipogenesis via the AMPK, MAPK, and AKT Signaling Pathways. Antioxidants 2022;11:1890

- Haiyan He, Yaoying Ma, Huaxing Huang, Chao Huang, Zhuo Chen, Dongjian Chen, Yiming Gu, Xiaohua Wang, Jinliang Chen. A comprehensive understanding about the pharmacological effect of diallyl disulfide other than its anti-carcinogenic activities. European Journal of Pharmacology 2021;893:173803

- Eun-Jung Rhee. Current status of obesity treatment in Korea: based on the 2020 Korean Society for the Study of Obesity guidelines for obesity management. J Korean Med Assoc 2022;65:388

- Maja Cigrovski Berkovic, Ines Bilic-Curcic, Anna Mrzljak, Silvija Canecki Varzic, Vjekoslav Cigrovski. Prehabilitation of overweight and obese patients with dysglycemia awaiting bariatric surgery: Predicting the success of obesity treatment. World J Diabetes 2022;13:1096
